BioSpace News Archive

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today provided a corporate update and reported financial results for its fiscal year 2023 third quarter ended December 31, 2022.

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced that company management will participate in the SVB Securities Global Biopharma Conference and Cowen’s 43rd Annual Health Care Conference.

SINTX Technologies, Inc. today announced the pricing of its public offering of 2,150,000 units, with each unit consisting of one share of its common stock, or one pre-funded warrant to purchase one share of its common stock, one Class C Warrant with each warrant to purchase one share of common stock, and one half of one Class D Warrant with each whole warrant to purchase one share of common stock.

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH) today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its voting common stock at a price to the public of $4.00 per share.

BioSig Technologies, Inc. today announced the retirement of chief financial officer Steve Chaussy following a distinguished career with the Company, and has named Steve Buhaly as his successor.

Nectin Therapeutics Ltd. announced today that it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the United States and Canada ).

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, February 27 , at 4:30 p.m. ET to discuss fourth quarter and full-year 2022 financial results and provide a general business update.

Harmony Biosciences Holdings, Inc. today announced that it will report fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023, before the open of the U.S. financial markets.

Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2023 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 1:50 PM ET on Tuesday, February 21, 2023.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and AltemisLab, leaders of sample management consumables and equipment to optimize inventory management workflows, today announced a collaboration that will streamline sample management automation for customers.